Dr. Atibalentja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2019 - 2022
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2016 - 2019
University of California San Francisco School of MedicineClass of 2016
Publications & Presentations
PubMed
- A big step for MYC-targeted therapies.Danielle F Atibalentja, Anja Deutzmann, Dean W Felsher
Trends in Cancer. 2024-05-01 - Expanding the Reach of Personalized Medicine in Cancer Care: Current Progress and Future Directions of.Yushu Shi, J Bryan Iorgulescu, Stephanie Valladao, Danielle F Atibalentja
JCO Precision Oncology. 2024-05-01 - 23 citationsAnti-PD-L1 F(ab) Conjugated PEG-PLGA Nanoparticle Enhances Immune Checkpoint Therapy.Christina K Lee, Danielle F Atibalentja, Lilian E Yao, Jangho Park, Sibu Kuruvilla
Nanotheranostics. 2022-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
